Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > New Distribution Agreement With Boehringer Ingelheim Offers Sigma-Aldrich Customers Expanded Biodegradable Polylactide Polymers for Biomaterials Research

Abstract:
RESOMER(R) Biodegradable Polymer Line can Support all Phases of the Drug Discovery and Development Pipeline

New Distribution Agreement With Boehringer Ingelheim Offers Sigma-Aldrich Customers Expanded Biodegradable Polylactide Polymers for Biomaterials Research

St. Louis, MO | Posted on April 9th, 2010

Sigma-Aldrich® (Nasdaq: SIAL) announced today it has entered into a distribution agreement with Boehringer Ingelheim Pharma GmbH & Co. KG, Germany, to offer its portfolio of RESOMER biodegradable polylactide (PLA) and poly(lactide-co-glycolide) (PLGA) polymers to the research community. Offered under Aldrich® Chemistry's Materials Science initiative, RESOMER polymers will be available for use in research and development applications, with a reliable supply of chemically identical GMP materials for scale-up and commercialization made available from Boehringer Ingelheim. The agreement provides an important, seamless supply of polymer products to support biomaterials research. A complete product list is available at www.sigma-aldrich.com/poly.

PLA and PLGA polymers are biodegradable polyesters that degrade in the body by simple hydrolysis of the ester backbone to non-harmful and non-toxic compounds. The degradation products are either excreted by the kidneys or eliminated as carbon dioxide and water through well-known biochemical pathways. Current applications of the polymers include surgical sutures and resorbable implants, with significant interest to further expand the use of these materials to drug encapsulation and delivery applications. Because PLA/PLGA polymers are considered safe, non-toxic and biocompatible by regulatory agencies in virtually all developed countries, additional applications of these materials can be brought to market more quickly and cost effectively than those utilizing a novel polymer with unproven biocompatibility.

"PLA, PLGA and their copolymers are some of the most frequently used polymer materials studied for biomedical applications with properties that can be tuned by changing the polymer composition within the basic PLA/PLGA theme," said Dr. Ilya Koltover, Market Segment Manager for Aldrich Materials Science. "These polymers have been used successfully in a number of approved medical applications, making them a fundamental platform technology for biomaterials research. Through our agreement with Boehringer Ingelheim, we can ensure scientists around the globe a reliable, seamless supply of these high quality materials, from research to GMP to support all phases of drug discovery and development."

The Aldrich RESOMER offer consists of twelve PLA/PLGA copolymers, as well as a related biodegradable polymer poly(dioxanone), with plans for future expansion. The new portfolio complements Aldrich's current selection of polymers for biomedical applications, which includes an extensive offer of functionalized poly(ethylene glycol) PEG polymers and natural biocompatible polymers.

The foregoing release contains forward-looking statements that can be identified by terminology such as "fundamental platform technology," "are considered safe," "more cost effectively" or similar expressions, or by express or implied discussions regarding the RESOMER products, or regarding potential future revenues from information derived therefrom. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that information derived from the RESOMER products will continue to meet the demands of the marketplace. Nor can there be any guarantee that the RESOMER products will achieve any particular levels of revenue in the future. In particular, management's expectations regarding these web tools could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

####

About Sigma-Aldrich
Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. Sigma-Aldrich has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,700 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service.

Sigma-Aldrich and Aldrich are registered trademarks of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co. RESOMER® is a registered trademark of Bohringer Ingelheim Pharma GmbH & Co. KG, Germany.

For more information, please click here

Contacts:
Sean Battles
Sigma-Aldrich
314-286-7616

Copyright © Sigma-Aldrich

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

East China University of Science and Technology Purchases Nanonex Advanced Nanoimprint Tool NX-B200 July 30th, 2014

Watching Schrödinger's cat die (or come to life): Steering quantum evolution & using probes to conduct continuous error correction in quantum computers July 30th, 2014

From Narrow to Broad July 30th, 2014

FLAG-ERA and TNT2014 join efforts: Graphene Networking at its higher level in Barcelona: Encourage the participation in a joint transnational call July 30th, 2014

Nanomedicine

New imaging agent provides better picture of the gut July 30th, 2014

Zenosense, Inc. July 29th, 2014

Optimum inertial design for self-propulsion: A new study investigates the effects of small but finite inertia on the propulsion of micro and nano-scale swimming machines July 29th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Announcements

University of Manchester selects Anasys AFM-IR for coatings and corrosion research July 30th, 2014

Nature inspires a greener way to make colorful plastics July 30th, 2014

Analytical solutions from Malvern Instruments support University of Wisconsin-Milwaukee researchers in understanding environmental effects of nanomaterials July 30th, 2014

FEI Unveils New Solutions for Faster Time-to-Analysis in Metals Research July 30th, 2014

Alliances/Partnerships/Distributorships

Nature inspires a greener way to make colorful plastics July 30th, 2014

SouthWest NanoTechnologies Names NanoSperse as A SWeNT Certified Compounder July 29th, 2014

ACS Biomaterials Science & Engineering™: Brand-new journal names editor July 29th, 2014

A*STAR and industry form S$200M semiconductor R&D July 25th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE